Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

FLAVOXATE HCL 100 MG TABLET

Flavoxate Hydrochloride
$0.6469per EA

Strength

100 mg/1

Manufacturer

Epic Pharma LLC

NDC

42806005801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

FLAVOXATE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076835

On Market Since

2/21/2011

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price History

1W

0.0%

1M

-3.6%

3M

-11.8%

6M

-18.6%

1Y

-9.7%

3Y

+0.6%

5Y

+5.6%

All

-18.1%

Generic Alternatives

1 alternative • Same active ingredient

FLAVOXATE HCL 100 MG TABLET
Generic
24658072001•PuraCap Laboratories LLC
$0.6943
+7% more

Related Drugs

Same classification

OXYBUTYNIN 5 MG/5 ML SYRUP
Generic
54838051080•Lannett Company Inc.
$0.0321
per ML
OXYBUTYNIN 5 MG/5 ML SOLUTION
Generic
62135052047•Chartwell RX LLC
$0.0321
per ML
OXYBUTYNIN 5 MG TABLET
Generic
64380078108•Strides Pharma Inc.
$0.0468
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003800•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003801•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003810•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003850•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00904702761•Major Pharmaceuticals
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
10702020101•KVK-Tech Inc.
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
10702020110•KVK-Tech Inc.
$0.0484
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy